Market Overview:
The global cyclic olefin prefillable injection device market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for minimally invasive surgeries and rising prevalence of chronic diseases. In addition, technological advancements in cyclic olefin prefillable injection devices are also contributing to the growth of this market. Based on type, the global cyclic olefin prefillable injection device market is segmented into crystal clear polymer (CCP), cyclic olefin polymer (COP), and cyclic olefin copolymer (COC). The CCP segment is expected to grow at a higher CAGR than other segments during the forecast period from 2018 to 2030. This can be attributed to its properties such as transparency, biocompatibility, and non-toxicity which make it suitable for use in medical applications. Based on application, the global Cyclic Olefin Prefillable Injection Device Market is segmented into hospital, clinic, and others.
Product Definition:
Cyclic Olefin Prefillable Injection Device is a device that helps in the administration of cyclic olefin monomer (COM) for the production of optical fibers. COM is a key ingredient in the manufacture of optical fiber and this device helps to improve the efficiency and reduce costs associated with its delivery.
Crystal Clear Polymer (CCP):
Crystal clear polymer (CCP) is a kind of cyclic olefin polymers. It has high molecular weight and low density, which makes it ideal for injection molding applications. The material has excellent chemical resistance, good clarity, and transparency as well as the ability to withstand a range of temperatures after injection molding making process.
Cyclic Olefin Polymer (COP):
Cyclic olefin polymer (COP) is a kind of thermoplastic elastomer, which has high resistance to heat and chemicals. It can be re-molded after being injection molded. COP exhibits superior properties such as high tensile strength, impact resistance, excellent surface finish and good processability for making complex shapes. These are the major factors that drive the demand for COP in pre-filled syringes market globally.
Application Insights:
The others application segment dominated the global cyclic olefin prefillable injection device market in 2017, accounting for a share of over 40.0% in terms of revenue. The application segment includes dental clinics, veterinary clinics and medical imaging centers among others. Increasing demand for injectable products from medical imaging centers is expected to drive the growth of this segment during the forecast period due to increasing usage of injectables such as contrast media and radiographic image guidance devices which require copolymerase chain reaction (PCR) services on a daily basis across various applications globally.
Increasing demand for minimally invasive procedures has fueled demand for COPD drugs across Europe.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to witness a CAGR of XX% during the forecast period. Increasing healthcare spending and rising awareness about pre-filled syringes are key factors driving the demand for DCOID devices in this region. In addition, growing medical tourism due to low treatment costs and availability of skilled professionals is also contributing towards increased adoption of medical devices such as cyclic olefin pre-filled injectable device by clinicians across various hospitals & clinics in developing economies such as India, China, Malaysia & Thailand.
The Asia Pacific market was closely followed by Europe with a revenue share of around 55%.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global Cyclic Olefin Prefillable Injection Device market is expected to grow at a CAGR of 7.5% during the forecast period owing to the increasing demand for minimally invasive surgeries. This is because these surgeries are less painful and have shorter recovery times as compared to traditional surgery procedures.
- Technological advancements: The development of novel technologies in the field of medical devices is expected to drive the growth of the Cyclic Olefin Prefillable Injection Device market during the forecast period. For instance, in 2017, Terumo Corporation introduced a new product called “AeroForm” which is an endoscopic air insufflation device that helps in performing laparoscopic surgery procedures with reduced surgical time and trauma. Such technological advancements are likely to increase adoption of Cyclic Olefin Prefillable Injection Devices among surgeons worldwide.
- Rising prevalence of chronic diseases: The global prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is rising rapidly due to changing lifestyles and aging population across the world. This has led healthcare providers to increasingly adopt minimally invasive surgical techniques such as laparoscopy for treatment purposes thereby driving demand for Cyclic Olefin Prefillable Injection Devices globally .
Scope Of The Report
Report Attributes
Report Details
Report Title
Cyclic Olefin Prefillable Injection Device Market Research Report
By Type
Crystal Clear Polymer (CCP), Cyclic Olefin Polymer (COP), Cyclic Olefin Copolymer (COC)
By Application
Hospital, Clinic, Others
By Companies
Abbott, Johnson & Johnson, Novartis AG, Novo Nordisk A/S, Taisei Kako, Merit Medical, Terumo, Daikyo Seiko, Mitsubishi, BD, AbbVie Incorporated, Baxter
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Cyclic Olefin Prefillable Injection Device Market Report Segments:
The global Cyclic Olefin Prefillable Injection Device market is segmented on the basis of:
Types
Crystal Clear Polymer (CCP), Cyclic Olefin Polymer (COP), Cyclic Olefin Copolymer (COC)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Johnson & Johnson
- Novartis AG
- Novo Nordisk A/S
- Taisei Kako
- Merit Medical
- Terumo
- Daikyo Seiko
- Mitsubishi
- BD
- AbbVie Incorporated
- Baxter
Highlights of The Cyclic Olefin Prefillable Injection Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Crystal Clear Polymer (CCP)
- Cyclic Olefin Polymer (COP)
- Cyclic Olefin Copolymer (COC)
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cyclic Olefin Prefillable Injection Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A cyclic olefin prefillable injection device is a type of medical device that uses an injectable form of cyclic olefin to provide short-term pain relief.
Some of the major players in the cyclic olefin prefillable injection device market are Abbott, Johnson & Johnson, Novartis AG, Novo Nordisk A/S, Taisei Kako, Merit Medical, Terumo, Daikyo Seiko, Mitsubishi, BD, AbbVie Incorporated, Baxter.
The cyclic olefin prefillable injection device market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cyclic Olefin Prefillable Injection Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cyclic Olefin Prefillable Injection Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cyclic Olefin Prefillable Injection Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cyclic Olefin Prefillable Injection Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cyclic Olefin Prefillable Injection Device Market Size & Forecast, 2020-2028
4.5.1 Cyclic Olefin Prefillable Injection Device Market Size and Y-o-Y Growth
4.5.2 Cyclic Olefin Prefillable Injection Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Crystal Clear Polymer (CCP)
5.2.2 Cyclic Olefin Polymer (COP)
5.2.3 Cyclic Olefin Copolymer (COC)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cyclic Olefin Prefillable Injection Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cyclic Olefin Prefillable Injection Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Crystal Clear Polymer (CCP)
9.6.2 Cyclic Olefin Polymer (COP)
9.6.3 Cyclic Olefin Copolymer (COC)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Crystal Clear Polymer (CCP)
10.6.2 Cyclic Olefin Polymer (COP)
10.6.3 Cyclic Olefin Copolymer (COC)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Crystal Clear Polymer (CCP)
11.6.2 Cyclic Olefin Polymer (COP)
11.6.3 Cyclic Olefin Copolymer (COC)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Crystal Clear Polymer (CCP)
12.6.2 Cyclic Olefin Polymer (COP)
12.6.3 Cyclic Olefin Copolymer (COC)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Crystal Clear Polymer (CCP)
13.6.2 Cyclic Olefin Polymer (COP)
13.6.3 Cyclic Olefin Copolymer (COC)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cyclic Olefin Prefillable Injection Device Market: Competitive Dashboard
14.2 Global Cyclic Olefin Prefillable Injection Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Johnson & Johnson
14.3.3 Novartis AG
14.3.4 Novo Nordisk A/S
14.3.5 Taisei Kako
14.3.6 Merit Medical
14.3.7 Terumo
14.3.8 Daikyo Seiko
14.3.9 Mitsubishi
14.3.10 BD
14.3.11 AbbVie Incorporated
14.3.12 Baxter
